University of Miami Health Center Purchases MicroThermX Microwave Ablation System

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com&esheet=50333501&lan=en-US&anchor=www.BSDMedical.com&index=1&md5=7e5159dabdb41fed4857ed37831158e6">www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced that the Company has sold a MicroThermX Microwave Ablation System (MicroThermX) to the University of Miami Hospital and Clinics (UMHC) to include the Sylvester Comprehensive Cancer Center (Sylvester) and the University of Miami Hospital. The MicroThermX will be used in both centers.

Sylvester/UMHC serves as the hub for cancer diagnosis and treatment throughout the South Florida area. The UMHC comprehensive network includes three hospitals, more than 30 outpatient facilities, and more than 1,500 physicians and scientists. Sylvester treats more than 4,100 new cancer patients each year, and has transformed cancer research and treatment in South Florida.

"We are excited to have state-of-the-art ablation treatment with the MicroThermX available in these prestigious cancer care facilities," stated Sam Maravich, BSD's vice president of Sales and Marketing. “UMHC purchased the MicroThermX following extensive clinical evaluations. Sylvester previously offered only radiofrequency (RF) ablation, but decided to acquire the MicroThermX because of its technological advantages. Published studies have demonstrated that microwave ablation has multiple advantages over RF ablation, and the innovative design of the MicroThermX provides physicians the ability to precisely target the ablation zone to numerous sizes and shapes of tumors."